Compare Firy Inc. (FIRY) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Firy Inc. vs Repligen Corporation Common Stock — how do they compare? Firy Inc. trades at $11.27 (market cap $206.28M), while Repligen Corporation Common Stock trades at $178.86 (market cap $11.14B). The key difference: Repligen Corporation Common Stock is far larger — about 54× Firy Inc.'s market cap, and Firy Inc. is more actively traded (112,784 versus 1,259,263). Which is the better fit depends on your goals — on Pluang, investors hold Firy Inc. for 13 Days and Repligen Corporation Common Stock for 0 Days on average.
| FIRY | RGEN | |
|---|---|---|
Market Cap | $206.28M | $11.14B |
Volume | 112,784 | 1,259,263 |
Sector | Technology | Health |
52-Week High | $13.10 | $194.57 |
52-Week Low | $2.28 | $102.87 |
Typical Hold Time | 13 Days | 0 Days |
Enterprise Value | $174.88M | $11.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIRY (formerly Skillz Inc.) trades at $11.17, down 9.85% in the last session. The technical outlook is bullish based on moving averages, though oscillators are neutral. Fundamentally, the company shows persistent losses with a net income margin of -60.23% despite an 87.76% gross margin. Recent developments include a $719 million legal victory and board additions, but cash burn remains a concern with negative operating cash flow of $68.93 million in 2025.
The outlook is cautious. While the legal win and strategic shifts offer potential upside, sustained losses and negative cash flow pose significant risks. Analyst sentiment is mixed with 60% hold ratings. Key catalysts include the collection of the legal judgment and improved operational efficiency, but investors face substantial execution and liquidity risks.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Firy Inc.
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
